XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Organization and Business Overview (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 9 Months Ended
Oct. 24, 2025
Oct. 31, 2025
Jul. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Jun. 16, 2025
Dec. 31, 2024
Preferred stock, par value         $ 0.001   $ 0.001 $ 0.001
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation         $ 10,985 $ 9,253    
Retained Earnings (Accumulated Deficit)         133,585     $ 117,409
Cash and Cash Equivalent         3,417     $ 5,905
Private Placement [Member]                
Proceeds from Issuance of Private Placement     $ 8,500   $ 11,000      
Subsequent Event [Member] | Private Placement [Member]                
Proceeds from Issuance of Private Placement   $ 2,500            
Subsequent Event [Member] | Investor [Member]                
Investment $ 11,000              
Investment 8,500              
Remaining investment $ 2,500              
Biofrontera Group [Member]                
Royalty percentage       12.00%        
Biofrontera Group [Member] | Series D Convertible Preferred Stock [Member]                
Shares issued       3,019        
Preferred stock, par value       $ 0.001 $ 1,000